Purpose of the development: The therapeutic perspectives in the treatment of cardiovascular diseases, cancer, neurological immune diseases, diabetes, ischemia, Alzheimer's and Parkinson's, slows the aging process

Recommended application field: Pharmacy and Medicine.

Advantages over analogues: The drug is derived from the primary plant material that does not pollute the environment. Has a number of economic advantages. The entire process is non-toxic and provides a range of products and expansion of nutratsevt for pharmacy and medicine.

The development stage readiness: Ready for application

Technical and economic effect: Patents: № 132, 146, 4104

Description of the development:
()
Complex biological product containing astaxanthin is derived from the biomass of green algae HAEMATOCOCCUS PLUVIALIS the original technology of extraction of transition and stabilization in a variety of vegetable oils: sunflower, corn, walnut, olive, grape seed. Technology for producing astaxanthin preparation in vegetable oils consists in mixing the biomass with oil within 3 hours. Before mixing with the oil biomass is subjected to acid hydrolysis to break the cell wall. Astaxanthin is completely transferred from biomass to oil, and extraction time is reduced by 16 times. The technology provides a rapid transition astiksantina, which has a strong lipophilic properties of oil.

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Moldova

For additional information turn to:
E-mail: gal@uintei.kiev.ua